University of California, Davis, College of Biological Sciences, Davis, CA 95616, USA.
2 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
A narrative review synthesizing current knowledge on KRAS biology, immunology, and therapeutic strategies across cancer types, offering a conceptual framework and recommendations for future combination approaches rather than reporting new empirical data.
Preclinical study in transgenic mice demonstrating mechanism of a novel compound on hypoxia-accelerated AD pathology, without clinical translation or comparative efficacy data.